Tailoring disease-modifying therapy approaches across multiple sclerosis sub-populations.

Aboseif A, Zeydan B, Nathoo N, Kantarci OH, Amezcua L, Voskuhl R, Bove R, Hua LH, Ontaneda D, Conway DS, et al.